MarksMan Healthcare

Meet MarksMan Healthcare at the Asian Federation of Cardiology Congress | Nov 8-10, Singapore Excited to announce that Dr. Richa Goyal will be representing MarksMan Healthcare at the upcoming Asian Federation of Cardiology Congress in Singapore, Nov 8-10, 2024! With our deep expertise in cardiovascular research, we've consistently delivered impactful insights in areas like atrial fibrillation, heart failure, lipid management, and hypertension. From patient-centered studies to health economics and real-world evidence, our work has empowered healthcare professionals and stakeholders with data-driven solutions. We're always looking to collaborate with pharma and medical device professionals who aim to elevate evidence generation and optimize treatment strategies. If you’re attending, don’t miss the chance to connect! Schedule a meeting with us in Singapore: enquiry@marksmanhealthcare.com Looking forward to inspiring discussions and exploring synergies for advancing cardiovascular health!

Explore our latest blog that delves into the critical role of patients and caregivers in health preference and patient-reported outcomes research. Their insights are vital for creating healthcare solutions that truly reflect patient needs and improve care effectiveness. Learn how integrating their perspectives can lead to more personalized and impactful healthcare. Dive into the details on our website! #MarksManHealthcare #BlogPost #PatientCare #HealthcareResearch #PROs #HPR

Check out our latest blog post on "Tiered Pricing for Varied Markets: Is It of Value to Patient Access?". Dive into how this strategy can improve access to life-saving medications while balancing affordability and financial sustainability. #MarksManHealthcare #BlogPost #Pharma #PatientAccess #TieredPricing #HealthcareInnovation

Reflecting on an Incredible Experience at #MarCon2024! We had a fantastic time at the CIMICON Event Series in Berlin, where we presented key insights on "Enhancing Evidence for Impact and Amplifying Market Access to Key Audiences" and hosted the Payer Engagement Café session. From dynamic discussions on #RWE and #EvidenceGeneration to engaging with thought leaders on payer engagement and #MarketAccess challenges, it was an enriching few days. Thank you to everyone who connected with us and shared in these conversations. Looking forward to many more collaborations ahead! #HEOR #MedicalAffairs #EvidenceBasedMedicine #HealthcareInnovation #HTA #EconomicModeling

Congratulations Dennis!

Experts from MarksMan Healthcare gave leadership talks on 5th October for IIM Jammu HAHM students. While Dr Vallish Nagendra spoke on the topic "An Introduction to the HEOR/ RWE Industry", wherein he introduced the concepts of HEOR, SLR, HTA, and RWE; Ms. Pradeepti Chopra engaged the students on the topic "Pharma Competitive Intelligence: Strategies for Success". Both talks were well received by the students, and were especially important because the students as such did not have first-hand exposure to both these industries. Students were particularly interested to know how their education and exposure to various facets of an MBA course would be helpful in the context of the HEOR/ RWE/ CI industry. #HEOR #MarketAccess #RWE #HTA #LiteratureReviews #CompetitiveIntelligence

Assessing treatments for rare diseases comes with unique challenges - small populations and diverse conditions make traditional methods less effective. Our latest blog explores the Win Ratio method, a statistical approach that overcomes these hurdles by prioritizing clinically important outcomes and offering a more nuanced evaluation of treatment effects. Discover how the Win Ratio is transforming rare disease research and providing deeper insights into treatment efficacy. #MarksManHealthcare #BlogPost #RareDiseases #ClinicalResearch #WinRatio #InnovativeApproaches #HealthcareResearch

To successfully transition a pharmaceutical product from development to market adoption, meticulous planning to define its value is essential. Our latest blog explores how proactively defining value early in the development cycle can align strategies to meet the specific requirements of patients, healthcare providers, payers, and regulatory bodies. Read more on our website. #MarksManHealthcare #BlogPosts #Pharmaceuticals #Healthcare #PersonalizedMedicine #MarketAdoption #ValueDefinition #StakeholderEngagement

Pharma MarCon 2024 is Europe’s leading event for market access and medical affairs professionals in pharma, biotech, and life sciences, gathering over 120 senior professionals for unparalleled networking and collaboration opportunities. We are excited to be part of this significant event and hope to connect with you there. CC - Dr. Amit Dang, Ms. Dimple Dang, Dr. Richa Goyal and Dr Vallish Nagendra #HEOR #RWE #MedicalAffairs #CompetitiveIntelligence

We are excited to announce our participation in the upcoming Pharma MarCon 2024 conference, taking place from October 06 – 08, 2024, at Hotel Titanic Chaussee, Berlin organised by we.CONECT - Discover a unique B2B event experience! Dr. Amit Dang and Ms. Dimple Dang will be hosting a session on "Enhancing Evidence for Impact and Amplifying Market Access to Key Audiences". This session will delve into strategies for leveraging evidence to enhance market access, a critical area for pharmaceutical and biotech companies seeking to maximize their market potential. CC - Dr. Richa Goyal and Dr Vallish Nagendra